DAIC Articles

Aug 9, 2021 | DAIC Articles
Study Compares Interventional Pulmonary Embolism Therapy in Combination With Anticoagulation to Anticoagulation Alone

Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk […]

Jul 1, 2021 | DAIC Articles
FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events

The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation AngelMed Guardian device. It is the world’s first implantable cardiac detection monitor and patient-warning system for acute coronary syndrome (ACS) events, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery […]

Jun 2, 2021 | DAIC Articles
Bracco Moving Forward With HLT Meridian TAVR Valve

The HLT Meridian TAVR Valve System is designed to overcome some of the challenges of current FDA-cleared TAVR devices.

May 19, 2021 | DAIC Articles
ECMO Increased Survival in Refractory Out-of-Hospital Cardiac Arrest

This “hyperinvasive” approach performed better than expected outcomes also seen in patients who received standard advanced cardiac life support.

May 10, 2021 | DAIC Articles
Vendors and ACC Collaborate With Consumer Technology Association to Help Clinicians and Patients Understand Cardiovascular Devices

The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health.

Apr 21, 2021 | DAIC Articles
Creating a Structural Heart Program is an Investment in the Future of the Hospital

Today, as TAVR now makes up more procedural volume in the U.S. than surgical aortic replacements, many hospitals that have not already created a structural heart program are now looking at creating one.

Apr 19, 2021 | DAIC Articles
Gene Therapy for Atrial Fibrillation Will Be Investigated With $3.67 million NIH Grant

National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant of $462,689 to Rhythm Therapeutics Inc. (RTI) to complete the phase 1 segment of the development of a novel gene therapy to treat atrial fibrillation (AF). It involves using electroporation to create temporary openings in cardiac cells to deliver therapeutic transgenes targeting the underlying […]

Apr 14, 2021 | DAIC Articles
First Patient Treated in Elixer Dynamx Coronary Bioadaptor Stent Technology

Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX Coronary Bioadaptor System, the first drug-eluting coronary stent that adapts to vessel physiology.

Apr 12, 2021 | DAIC Articles
Medtronic Recalls its ICDs and CRT-Ds Due to Risk of Rapid Battery Depletion

Class I recall includes Evera, Viva, Brava, Claria, Amplia, Compia and Visia implantable cardioverter defibrillators and cardiac resynchronization therapy devices.

Apr 1, 2021 | DAIC Articles
Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

In the early 2000s, the cardiology department at WHS Washington Hospital needed to replace an outdated paper reporting system with a modern system that could streamline workflows, reduce redundant data entry, and balance workloads.

Filter by Journal